ArticleFrontiers in nutrition2025
Associations of comprehensive dietary antioxidant index with postmenopausal femur bone mineral density and osteoporosis: data from the national health and nutrition examination survey.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The study aimed to explore associations of the comprehensive dietary antioxidant index (CDAI) with femur bone mineral density (BMD) and risk of osteoporosis in American postmenopausal women. Methods: A total of 2,862 participants from the National Health and Nutrition Examination Survey were included in this study. The relationship between the CDAI and femur BMD was assessed via weighted multivariate linear regression model. The odds ratios (ORs) and 95% confidence intervals (95% CIs) for the association between the CDAI and the risk of osteoporosis was assessed by weighted logistic regression model. Moreover, the nonlinear relationship was also characterized by smooth curve fitting and weighted generalized additive model. The two-piecewise linear regression models and a recursive algorithm were used to find the inflection points. Results: After adjusting all covariates, the weighted multivariable linear regression models demonstrated that the CDAI was positively correlated with femur BMD. Moreover, there were nonlinear relationships between CDAI and risk of osteoporosis. In the age below 70 years, the risk of osteoporosis decreased to 60.6 and 92.2% with each unit increase in CDAI value before and after the inflection point (-2.268), respectively. In the 70 years or older, the risk of osteoporosis decreased to 80.4% with each unit increase in CDAI value before the inflection point (-1.479). The weighted logistic regression model demonstrated that compared to the first tertile of CDAI, the highest tertile of CDAI was significantly associated with a lower risk of osteoporosis, with ORs of 0.375 (95% CI 0.284, 0.495) for individuals under the age of 70, and 0.626 (95% CI 0.481, 0.814) for individuals aged 70 or above. Conclusion: The present study indicated that postmenopausal women with higher CDAI scores have a lower risk of osteoporosis. In addition, there is a non-linear relationship between CDAI and the risk of osteoporosis. This finding suggests that the adoption of a comprehensive antioxidant dietary structure represented by high CDAI scores may have a positive impact on the prevention and management of osteoporosis in postmenopausal women. Particularly for those with lower CDAI scores, early screening and intervention for osteoporosis may be necessary.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.